May 7, 2014
Creoptix to Support the 15th Annual Drug Discovery Summit 2014
See you in Geneva!
Creoptix AG today announced the participation in the 15th Annual Drug Discovery Summit to be held in Geneva, Switzerland, June 2 & 3, 2014.
Supporting this conference allows Creoptix to present its innovative system for label-free analysis of molecular interactions by waveguide-interferometry technology. The system is characterized by highest sensitivity addressing the demanding needs of the drug discovery industry, such as improved fragment-based screening, binding analysis at low concentrations or accurate analysis of slow dissociation kinetics. Smart disposable sensor chips having integrated micro-fluidics and the user friendly software provide a reliable, high performance yet economic solutions to the industry.